These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19086767)

  • 1. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
    Rothman RB; Blough BE; Baumann MH
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):458-74. PubMed ID: 19086767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine/serotonin releasers as medications for stimulant addictions.
    Rothman RB; Blough BE; Baumann MH
    Prog Brain Res; 2008; 172():385-406. PubMed ID: 18772043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
    Rothman RB; Blough BE; Baumann MH
    AAPS J; 2007 Jan; 9(1):E1-10. PubMed ID: 17408232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.
    Rothman RB; Baumann MH
    Ann N Y Acad Sci; 2006 Aug; 1074():245-60. PubMed ID: 17105921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methcathinone and 3-Cl-methcathinone (PAL-434) in cocaine discrimination or self-administration in rhesus monkeys.
    Kohut SJ; Fivel PA; Blough BE; Rothman RB; Mello NK
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1985-98. PubMed ID: 23768644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
    Banks ML; Bauer CT; Blough BE; Rothman RB; Partilla JS; Baumann MH; Negus SS
    Exp Clin Psychopharmacol; 2014 Jun; 22(3):274-284. PubMed ID: 24796848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
    Rothman RB; Blough BE; Baumann MH
    Trends Pharmacol Sci; 2006 Dec; 27(12):612-8. PubMed ID: 17056126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
    Negus SS; Mello NK; Blough BE; Baumann MH; Rothman RB
    J Pharmacol Exp Ther; 2007 Feb; 320(2):627-36. PubMed ID: 17071819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of monoamine transporter substrates.
    Rothman RB; Baumann MH
    Curr Top Med Chem; 2006; 6(17):1845-59. PubMed ID: 17017961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appetite suppressants as agonist substitution therapies for stimulant dependence.
    Rothman RB; Blough BE; Baumann MH
    Ann N Y Acad Sci; 2002 Jun; 965():109-26. PubMed ID: 12105089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.
    Kohut SJ; Jacobs DS; Rothman RB; Partilla JS; Bergman J; Blough BE
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3455-3465. PubMed ID: 28889212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonergic system and its role in cocaine addiction.
    Filip M; Frankowska M; Zaniewska M; Gołda A; Przegaliński E
    Pharmacol Rep; 2005; 57(6):685-700. PubMed ID: 16382187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine.
    Negus SS; Baumann MH; Rothman RB; Mello NK; Blough BE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):272-81. PubMed ID: 19151247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.
    Bauer CT; Banks ML; Blough BE; Negus SS
    Br J Pharmacol; 2013 Feb; 168(4):850-62. PubMed ID: 22978626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.
    Müller CP; Carey RJ; Huston JP; De Souza Silva MA
    Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.